Orchid Chemicals & Pharmaceuticals Ltd.
Audited Financial Results for the year ended March 31, 2009
S.No
Particulars
Year ended
31-March-09
(Audited)
Year ended
31-March-08
(Audited)
Consolidated year ended 31-Mar-09
(Audited)
Consolidated year ended 31-Mar-08
(Audited)
1
 Net Sales
115,676.96

119,164.08
126,002.49
125,338.14
2
 Other Operating Income
5,450.12
4,849.94
5,553.28
4,760.15
3
Total Operating Income (1+2)
121,127.08
124,014.02
131,555.77
130,098.29
4
 Expenditure        

a) Decrease/(Increase) in Stock in trade
(6,478.32)
(1,933.77)
(7,246.23)
(2,530.48)
b) Material Cost
53,881.65
42,829.35
62,180.45
47,892.96
c) Purchase of Trades Goods
3,627.66
2,569.32
3,627.67
2,569.33
 
d) Employees Cost
12,227.49
9,989.76
13,685.11
11,714.18
 
e) Depreciation / Amortisation
12,997.21
9,766.78
13,399.25
10,067.84
 
f) Other Expenditure
29,296.36
35,954.29
29,607.07
36,456.38
g) Total
105,552.05
99,175.73
115,253.32
106,170.21
5
Profit from Operations before other Income, Interest & Exceptional Item (3 - 4)
15,575.03
24,838.29
16,302.45
23,928.08
6
Other Income
301.85
1.80
4.00
1.80
7
Profit before Interest & Exceptional Item (5+6)
15,876.88
24,840.09
16,306.45
23,929.88
8
 Interest & Finance Charges
15,518.60
8,112.63
15,645.00
8,200.05
9
Profit after Interest but before Exceptional Item (7-8)
358.28
16,727.46
661.45
15,729.83
10
Exceptional Item
(4,043.10)
7,126.67
(4,043.10)
7,126.67
11

Profit/ (Loss) before Tax (9+10)
(3,684.82)
23,854.13
(3,381.65)
22,856.50
12
Tax expenses
     - Current Tax & Deferred Tax
1,371.65
5,250.52
1,350.09
5,163.51
     - Fringe Benefit Tax
161.00
150.00
167.25
159.00
13
 Net Profit/ (Loss) after Tax (11-12)
(5,217.47)
18,453.61
(4,898.99)
17,533.99
14
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
7,044.21
6,585.08
7,044.21
6,585.08
15
 Reserves excluding Revaluation Reserves
59,977.31
62,224.44
56,335.56
59,912.92
16
 Basic Earnings per Share (EPS) Rs.
(7.61)
28.03
(7.14)
26.63
17
Diluted Earnings per share (EPS) Rs.
(7.61)
18.85
(7.14)
17.91
18
Aggregate of Public Shareholding
     - Number of equity shares
55,525,904
55,398,604
55,525,904
55,398,604
     - Percentage of Shareholding
78.82
84.13
78.82
84.13
19
Promoters and Promoter group shareholding
a. Pledged / Encumbered
- Number of shares
6,258,000
6,258,000
 
- Percentage of shares (as a % of the total shareholding of promoter and promoter group)
41.95
41.95
 
- Percentage of shares (as a % of the total share capital of company)
8.88
8.88
 
b. Non - Encumbered
 
- Numbers of shares
8,658,172
8,658,172
 
- Percentage of shares (as a % of the total shareholding of promoter and promoter group)
58.05
58.05
 
- Percentage of shares (as a % of the total share capital of company)
12.30
12.30

 
  1. 1 The above audited financial results were approved by the Board of Directors at its meeting held on Monday, June 29, 2009.
  2. The Company is operating in single segment (i.e) "Pharmaceuticals".
  3. The Board of Directors has recommended a dividend of Re. 1/- per share on the equity share of Rs.10/- each.
  4. The Company has exercised the option provided under the Companies (Accounting Standards) Amendment Rules, 2006 dated 31st March, 2009 in respect of AS 11. The amount remaining to be amortized in the financial statement as on 31st March, 2009 on account of exercising the above option during the current year is Rs. 8357.94 lakhs.
  5. Exceptional items at point no. 10 represents (i) exchange losses on FCCBs of Rs.2839.17 lakhs (Previous year gain of Rs.7126.67 lakhs), (ii) one time charge for rebates and discounts of Rs.4000 lakhs (Previous year Rs.Nil) and (iii) MTM losses on derivative instruments provided for, of Rs. 3934.46 lakhs (Previous year Rs.Nil), aggregate of the three netted off against profit on cancellation of FCCBs of Rs.6730.53 lakhs (Previous year Rs.Nil).
  6. The Company received 10 complaints during the quarter ended March 31, 2009 from the shareholders. All the complaints have been resolved and no complaints were pending as on March 31, 2009.
  7. Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : 29-06-2009

For and on behalf of the Board

K. Raghavendra Rao
Managing Director